• Exchange: NASDAQ CM
  • Sector: Health Care
  • Industry: Medical Equipment & Devices
  • Sub-Industry: Health Care Supplies

AXGN:US

3.8500 USD 0.1700 4.62%

As of 17:10:00 ET on 12/24/2014.

Snapshot for AxoGen Inc (AXGN)

Open: 3.6300 Day's Range: 3.5710 - 3.8500 Volume: 59,087
Previous Close: 3.6800 52wk Range: 2.1100 - 5.2000 1-Yr Rtn: +10.32%

Stock Chart for AXGN

No chart data available.
  • AXGN:US 3.8500
  • 1D
  • 1M
  • 1Y
3.6800
Interactive AXGN Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for AXGN

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -0.8759
Est. EPS (USD) (12/2014) -0.7900
Est. PEG Ratio -
Market Cap (M USD) 67.25
Shares Outstanding (M) 17.47
30 Day Average Volume 97,781
Price/Book (mrq) -
Price/Sale (ttm) 4.4731
Dividend Indicated Gross Yield -%
Cash Dividend (USD) 1.0000
Dividend Ex-Date 01/27/2010
5 Year Dividend Growth -
Next Earnings Announcement 03/06/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for AXGN

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for AXGN

AxoGen Corp is a regenerative medicine company focused on the development and commercialization of technologies for peripheral nerve reconstruction and regeneration. The Company offers products to help repair peripheral nerves.

Karen ZaderejPresident/CEOLee Robert Johnston Jr "Bob"Chief Financial Officer
Gregory G FreitagSenior VP:Bus Dev/General CnslShawn F McCarreySenior VP:Sales
More Company Profile & Key Executives for AXGN

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil